274 related articles for article (PubMed ID: 3905632)
1. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
2. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Klimt CR; Doub PH; Doub NH
Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
[TBL] [Abstract][Full Text] [Related]
4. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
5. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
[TBL] [Abstract][Full Text] [Related]
6. The anturane reinfarction trial.
Sherry S
Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
[TBL] [Abstract][Full Text] [Related]
7. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
8. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Klimt CR; Knatterud GL; Stamler J; Meier P
J Am Coll Cardiol; 1986 Feb; 7(2):251-69. PubMed ID: 2868029
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
10. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
11. [Platelet antiaggregants in the treatment of arterial thrombosis].
Ferlito S
Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
[TBL] [Abstract][Full Text] [Related]
12. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
[No Abstract] [Full Text] [Related]
13. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
14. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Cairns JA
Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
[No Abstract] [Full Text] [Related]
15. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
[TBL] [Abstract][Full Text] [Related]
16. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Castaldi PA
Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
18. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
Reikvam A; Madsen S; Landmark K
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention of stroke: does dipyridamole add to aspirin?
Lowenthal A; Buyse M
Acta Neurol Belg; 1994; 94(1):24-34. PubMed ID: 8140884
[TBL] [Abstract][Full Text] [Related]
20. Role of platelet inhibitor therapy in myocardial infarction.
Stein B; Fuster V
Cardiovasc Drugs Ther; 1989 Dec; 3(6):797-813. PubMed ID: 2487543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
